NeuroPace to Host Investor Day on January 28th in New York City
NeuroPace (NPCE), a medical device company specializing in epilepsy treatment, has announced an upcoming Investor Day scheduled for January 28, 2025, in New York City. The event will run from 9:00 a.m. to 12:00 p.m. ET.
The presentation will showcase the company's RNS technology and future strategic plans. Management will discuss recent results and outline market, product, and clinical development strategies for the RNS System. The event will feature presentations from clinical key opinion leaders and include personal testimony from an RNS patient about their experience with the system.
NeuroPace (NPCE), un'azienda di dispositivi medici specializzata nel trattamento dell'epilessia, ha annunciato un prossimo Investor Day previsto per il 28 gennaio 2025, a New York City. L'evento si svolgerà dalle 9:00 alle 12:00 ET.
La presentazione metterà in mostra la tecnologia RNS dell'azienda e i suoi futuri piani strategici. Il management discuterà i risultati recenti e delineerà strategie per il mercato, il prodotto e lo sviluppo clinico del Sistema RNS. L'evento presenterà le relazioni di leader di opinione clinici e includerà la testimonianza personale di un paziente RNS sulla propria esperienza con il sistema.
NeuroPace (NPCE), una empresa de dispositivos médicos especializada en el tratamiento de la epilepsia, ha anunciado un próximo Día del Inversor programado para el 28 de enero de 2025 en la ciudad de Nueva York. El evento se llevará a cabo de 9:00 a.m. a 12:00 p.m. ET.
La presentación mostrará la tecnología RNS de la empresa y sus futuros planes estratégicos. La dirección discutirá los resultados recientes y esbozará estrategias para el mercado, el producto y el desarrollo clínico del Sistema RNS. El evento contará con presentaciones de líderes de opinión clínica e incluirá el testimonio personal de un paciente RNS sobre su experiencia con el sistema.
NeuroPace (NPCE), 간질 치료에 전문화된 의료 기기 회사가 2025년 1월 28일 뉴욕시에서 예정된 투자자 데이를 발표했습니다. 이 행사는 오전 9시부터 오후 12시까지 (동부 표준시 기준) 진행됩니다.
발표에서는 회사의 RNS 기술와 향후 전략 계획을 소개할 것입니다. 경영진은 최근 결과를 논의하고 RNS 시스템을 위한 시장, 제품 및 임상 개발 전략을 설명할 것입니다. 이 행사는 임상 주요 의견 리더의 발표와 RNS 환자의 시스템 경험에 대한 개인적인 증언을 포함할 것입니다.
NeuroPace (NPCE), une entreprise de dispositifs médicaux spécialisée dans le traitement de l'épilepsie, a annoncé un prochain Investor Day prévu pour le 28 janvier 2025 à New York. L'événement se déroulera de 9h00 à 12h00, heure de l'Est.
La présentation mettra en valeur la technologie RNS de l'entreprise et ses futurs plans stratégiques. La direction discutera des résultats récents et exposera des stratégies de marché, de produit et de développement clinique pour le Système RNS. L'événement comprendra des présentations de leaders d'opinion clinique et un témoignage personnel d'un patient RNS sur son expérience avec le système.
NeuroPace (NPCE), ein Medizintechnikunternehmen, das sich auf die Behandlung von Epilepsie spezialisiert hat, hat einen bevorstehenden Investor Day angekündigt, der für den 28. Januar 2025 in New York City geplant ist. Die Veranstaltung findet von 9:00 bis 12:00 Uhr ET statt.
Die Präsentation wird die RNS-Technologie des Unternehmens vorstellen und zukünftige strategische Pläne erläutern. Das Management wird die jüngsten Ergebnisse besprechen und Markt-, Produkt- und klinische Entwicklungsstrategien für das RNS-System skizzieren. Die Veranstaltung umfasst Präsentationen von führenden klinischen Meinungsträgern und persönliche Erfahrungsberichte eines RNS-Patienten über seine Erfahrungen mit dem System.
- None.
- None.
MOUNTAIN VIEW, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will host an Investor Day from 9:00 a.m. – 12:00 p.m. ET on Tuesday, January 28, 2025 in New York City.
The Investor Day will provide an update on NeuroPace’s vision for its unique RNS technology and will highlight the Company’s plans including presentations from management discussing NeuroPace’s recent results, future plans, and market, product and clinical development strategies for the RNS System. The Company will also host guest speakers, including clinical key opinion leaders and an RNS patient who will provide their personal experience with the RNS System and its impact on their epilepsy.
Use the link below to register for the event:
https://lifescievents.com/event/neuropace/
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When and where is NeuroPace (NPCE) hosting its 2025 Investor Day?
What topics will be covered at NeuroPace's 2025 Investor Day?
Who will be speaking at the NPCE Investor Day 2025?
How can investors register for NeuroPace's 2025 Investor Day?
